DE69804302D1 - Kationische mittel zur transfektion von nukleinsäuren - Google Patents

Kationische mittel zur transfektion von nukleinsäuren

Info

Publication number
DE69804302D1
DE69804302D1 DE69804302T DE69804302T DE69804302D1 DE 69804302 D1 DE69804302 D1 DE 69804302D1 DE 69804302 T DE69804302 T DE 69804302T DE 69804302 T DE69804302 T DE 69804302T DE 69804302 D1 DE69804302 D1 DE 69804302D1
Authority
DE
Germany
Prior art keywords
nucleic acids
cationic agents
transfecting nucleic
cationic
transfecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69804302T
Other languages
English (en)
Other versions
DE69804302T2 (de
Inventor
Michel Bessodes
Daniel Scherman
Jean Herscovici
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE69804302D1 publication Critical patent/DE69804302D1/de
Publication of DE69804302T2 publication Critical patent/DE69804302T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE69804302T 1997-06-06 1998-06-03 Kationische mittel zur transfektion von nukleinsäuren Expired - Fee Related DE69804302T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707014A FR2764304B1 (fr) 1997-06-06 1997-06-06 Nouvelle classe d'agents transfectants cationiques des acides nucleiques
PCT/FR1998/001112 WO1998055490A1 (fr) 1997-06-06 1998-06-03 Nouvelle classe d'agents transfectants cationiques des acides nucleiques

Publications (2)

Publication Number Publication Date
DE69804302D1 true DE69804302D1 (de) 2002-04-25
DE69804302T2 DE69804302T2 (de) 2002-10-17

Family

ID=9507684

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69804302T Expired - Fee Related DE69804302T2 (de) 1997-06-06 1998-06-03 Kationische mittel zur transfektion von nukleinsäuren

Country Status (18)

Country Link
EP (1) EP0986568B1 (de)
JP (1) JP2002504815A (de)
KR (1) KR20010013312A (de)
CN (1) CN1259134A (de)
AT (1) ATE214708T1 (de)
AU (1) AU737579B2 (de)
BR (1) BR9809953A (de)
CA (1) CA2292837A1 (de)
DE (1) DE69804302T2 (de)
DK (1) DK0986568T3 (de)
ES (1) ES2174445T3 (de)
FR (1) FR2764304B1 (de)
HU (1) HUP0004577A3 (de)
NO (1) NO314147B1 (de)
PL (1) PL337177A1 (de)
PT (1) PT986568E (de)
WO (1) WO1998055490A1 (de)
ZA (1) ZA984845B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020058795A1 (en) * 1997-09-08 2002-05-16 Russ J. Mumper Hydrophobic glycosylamine derivatives, compositions, and methods for use
DE19942864A1 (de) * 1999-09-08 2001-03-15 Knoell Hans Forschung Ev Neue O-(Aminoalkyl)-Derivate von Monosacchariden, Verfahren zu ihrer Herstellung und ihre Verwendung als antibakterielle Mittel
FR2829136B1 (fr) * 2001-08-29 2006-11-17 Aventis Pharma Sa Derives lipidiques d'aminoglycosides
WO2003018603A1 (fr) * 2001-08-29 2003-03-06 Aventis Pharma S.A. Derives lipidiques d'aminoglycosides_pour la transfection
JP5107350B2 (ja) 2005-06-08 2012-12-26 アミカス セラピューティックス インコーポレイテッド イミノおよびアミノ糖の精製
JPWO2008081686A1 (ja) * 2006-12-28 2010-04-30 コニカミノルタホールディングス株式会社 コレステロール誘導体、リポソーム、リポソームの形成方法およびｘ線用造影剤
US10538784B2 (en) * 2016-03-01 2020-01-21 Molecular Transfer, Inc. Plant virus movement proteins and methods of using the same
US11964051B2 (en) * 2018-05-16 2024-04-23 Translate Bio, Inc. Ribose cationic lipids
MA53434A (fr) 2018-08-23 2021-12-01 Seagen Inc Anticorps anti-tigit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2774417B2 (ja) * 1991-08-07 1998-07-09 株式会社ディ・ディ・エス研究所 ペプチド骨格を有する分枝鎖型糖複合体及び微粒子キャリヤー
DE4329093A1 (de) * 1993-08-30 1995-03-02 Bayer Ag Substituierte Aminoalkylglycoside
AU4923696A (en) * 1995-02-10 1996-08-27 Nexstar Pharmaceuticals, Inc. Lipid constructs for cytoplasmic delivery of agents

Also Published As

Publication number Publication date
ATE214708T1 (de) 2002-04-15
NO995858L (no) 1999-11-30
DK0986568T3 (da) 2002-06-10
BR9809953A (pt) 2000-08-01
NO314147B1 (no) 2003-02-03
CA2292837A1 (fr) 1998-12-10
FR2764304B1 (fr) 1999-07-16
HUP0004577A3 (en) 2003-03-28
EP0986568A1 (de) 2000-03-22
ES2174445T3 (es) 2002-11-01
PL337177A1 (en) 2000-08-14
JP2002504815A (ja) 2002-02-12
NO995858D0 (no) 1999-11-30
PT986568E (pt) 2002-08-30
FR2764304A1 (fr) 1998-12-11
ZA984845B (en) 1998-12-29
HUP0004577A1 (hu) 2001-04-28
AU737579B2 (en) 2001-08-23
AU8025098A (en) 1998-12-21
EP0986568B1 (de) 2002-03-20
WO1998055490A1 (fr) 1998-12-10
DE69804302T2 (de) 2002-10-17
KR20010013312A (ko) 2001-02-26
CN1259134A (zh) 2000-07-05

Similar Documents

Publication Publication Date Title
PT983087E (pt) Composicao de vacina multivalente com veiculo misto
DE69840748D1 (de) Verfahren zur zubereitung von antisense oligonukleotiden
SE8901687D0 (sv) Fibronectin binding protein as well as its preparation
DE69839444D1 (de) Smad 6 und dessen anwendungen
ATE328896T1 (de) Faktor viii vom schwein und hybriden
DE3883743T3 (de) Aminosäuren, nützlich bei Leberstörungen.
DE69804302D1 (de) Kationische mittel zur transfektion von nukleinsäuren
DK0817851T3 (da) DNA, der koder for humant papillomvirus type 18
NO882380D0 (no) Fibfonektin-bindende protein, samt fremstilling derav.
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69934415D1 (de) Neuartiges collectin
ES2065472T3 (es) Composiciones de betun.
DE29501724U1 (de) Spachtel zur Nachbearbeitung von Silikonfugen o.dgl.
DE9404450U1 (de) Verteiler bzw. Zustellerwagen
DE69801789D1 (de) Verfahren zur Herstellung von optisch aktiven 1,2,4,-Butantriolen
DE69007944D1 (de) Kationische Elektrotauchlackierung-Zusammensetzung.
ATE237572T1 (de) Verfahren zur reiningung von 1,3,5- triisopropylbenzol
ES555466A0 (es) Mejoras introducidas en el objeto de la patente de invencion 516.212 por perfeccionamientos introducidos en atomizadores agricolas
MX9203129A (es) Proteinas bmp-5.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee